Diana Brainard, CEO, Director at AlloVir, holds 782.98K shares in AlloVir (Ticker: ALVR), holds 28.56K shares in Nektar Therapeutics (Ticker: NKTR). Most recently, Diana Brainard Sold ― shares of AlloVir on Jul 03, 2024 for an estimated value of 1.07K.